Rimmelzwaan GF - Search Results

1

Mapping the antigenic and genetic evolution of influenza virus.

Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Smith DJ, et al. Among authors: rimmelzwaan gf. Science. 2004 Jul 16;305(5682):371-6. doi: 10.1126/science.1097211. Epub 2004 Jun 24. Science. 2004. PMID: 15218094

2

[Influenza in the 1994/95 season; composition of vaccine for the 1995/96 season].

Claas EC, de Jong JC, Bartelds AI, Rimmelzwaan GF, van Wijngaarden JK, Osterhaus AD. Claas EC, et al. Among authors: rimmelzwaan gf. Ned Tijdschr Geneeskd. 1995 Oct 21;139(42):2154-8. Ned Tijdschr Geneeskd. 1995. PMID: 7477582 Dutch.

3

Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza?

Rimmelzwaan GF, Osterhaus AD. Rimmelzwaan GF, et al. Vaccine. 1995;13(8):703-5. doi: 10.1016/0264-410x(94)00030-q. Vaccine. 1995. PMID: 7483784 No abstract available.

4

Two different mutations in the envelope protein of feline immunodeficiency virus allow the virus to escape from neutralization by feline serum antibodies.

Siebelink KH, Bosch ML, Rimmelzwaan GF, Meloen RH, Osterhaus AD. Siebelink KH, et al. Among authors: rimmelzwaan gf. Vet Immunol Immunopathol. 1995 May;46(1-2):51-9. doi: 10.1016/0165-2427(94)07005-r. Vet Immunol Immunopathol. 1995. PMID: 7542412 Free article.

5

A novel generation of viral vaccines based on the ISCOM matrix.

Rimmelzwaan GF, Osterhaus AD. Rimmelzwaan GF, et al. Pharm Biotechnol. 1995;6:543-58. doi: 10.1007/978-1-4615-1823-5_23. Pharm Biotechnol. 1995. PMID: 7551235 Review. No abstract available.

6

Influenza types and patient population.

Claas EC, de Jong JC, Bartelds AI, Bijlsma K, Rothbarth P, de Groot R, Rimmelzwaan GF, Osterhaus AD. Claas EC, et al. Among authors: rimmelzwaan gf. Lancet. 1995 Jul 15;346(8968):180. doi: 10.1016/s0140-6736(95)91236-3. Lancet. 1995. PMID: 7603243 No abstract available.

7

A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization.

Siebelink KH, Rimmelzwaan GF, Bosch ML, Meloen RH, Osterhaus AD. Siebelink KH, et al. Among authors: rimmelzwaan gf. J Virol. 1993 Apr;67(4):2202-8. doi: 10.1128/JVI.67.4.2202-2208.1993. J Virol. 1993. PMID: 8383237 Free PMC article.

8

[Influenza in the 1995/'96 season; vaccine composition for the 1996/'97 season].

Claas EC, de Jong JC, Bartelds AI, Rimmelzwaan GF, van Wijngaarden JK, Osterhaus AD. Claas EC, et al. Among authors: rimmelzwaan gf. Ned Tijdschr Geneeskd. 1996 Oct 12;140(41):2047-50. Ned Tijdschr Geneeskd. 1996. PMID: 8965944 Dutch.

9

Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.

Rimmelzwaan GF, Baars M, van Beek R, van Amerongen G, Lövgren-Bengtsson K, Claas EC, Osterhaus AD. Rimmelzwaan GF, et al. J Gen Virol. 1997 Apr;78 ( Pt 4):757-65. doi: 10.1099/0022-1317-78-4-757. J Gen Virol. 1997. PMID: 9129647

10

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.

Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG. Claas EC, et al. Among authors: rimmelzwaan gf. Lancet. 1998 Feb 14;351(9101):472-7. doi: 10.1016/S0140-6736(97)11212-0. Lancet. 1998. PMID: 9482438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page